000 01269 a2200349 4500
005 20250514062041.0
264 0 _c20030328
008 200303s 0 0 eng d
022 _a0896-1263
040 _aNLM
_beng
_cNLM
100 1 _aRobers, Susan
245 0 0 _aThe ESRD regulatory landscape: a primer & resource. Part 2.
_h[electronic resource]
260 _bNephrology news & issues
_cJan 2003
300 _a22-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCenters for Disease Control and Prevention, U.S.
650 0 4 _aDrug and Narcotic Control
650 0 4 _aFederal Government
650 0 4 _aGovernment Regulation
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xeconomics
650 0 4 _aLicensure
650 0 4 _aMedicare Payment Advisory Commission
650 0 4 _aNational Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division
650 0 4 _aNephrology
_xeconomics
650 0 4 _aRenal Replacement Therapy
_xeconomics
650 0 4 _aState Government
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
650 0 4 _aUnited States Social Security Administration
773 0 _tNephrology news & issues
_gvol. 17
_gno. 2
_gp. 22-5
999 _c12424748
_d12424748